vitamin b9 + vitamin b12 Tablets, sublingual 660µg + 400µg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #653
This pharmaceutical company is a group of three collaborating entities focused on developing and producing innovative medications across diverse therapeutic areas. Key therapy areas include respiratory, cardiovascular, pain management, and dermatology. They offer a wide range of dosage forms including dry powder for inhalation, effervescent tablets, extended-release pellets, and traditional oral formulations like capsules and tablets. The company holds patents for several products, particularly in the food supplement sector, focusing on vitamin combinations and cholecalciferol (vitamin D3). They operate in major regions like North America and the EU.

Manufacturer usually replies in 7 days

None